SCHEMBL21116907

SCHEMBL21116907

c1ccc2cc3c(cc2c1)oc1cc(-c2nc(-c4ccc5c(c4)oc4ccccc45)nc(-c4ccc5c(c4)oc4ccccc45)n2)ccc13

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.47
▸ MAPT P10636 6/20 0.46
▸ KDM4E B2RXH2 5/20 0.46
▸ ALDH1A1 P00352 5/20 0.46
▸ HPGD P15428 5/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ NPC1 O15118 4/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ HCRTR1 O43613 1/20 0.43
▸ HSD17B10 Q99714 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAOA P21397 4/20 0.40
▸ TTR P02766 1/20 0.40
▸ HTR2B P41595 1/20 0.39
▸ CHEK2 O96017 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ MMP12 P39900 1/20 0.39
▸ MMP13 P45452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23283771 0.94 AHR (0.42) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL23283766 0.93 MAPT (0.41) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL15501707 0.91 AHR (0.55) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL24372704 0.90 AHR (0.45) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL23633531 0.90 AHR (0.47) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL21707172 0.90 MEN1 (0.42) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL23384905 0.90 AHR (0.47) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL21116763 0.90 MAPT (0.50) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL21116874 0.90 MAPT (0.50) AHRMAPTKDM4EALDH1A1HPGD
SCHEMBL22161439 0.89 MEN1 (0.41) AHRMAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190198780-A1 ORGANIC COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190198780-A1 ORGANIC COMPOUND AND COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OR51E2 AHR 2690/4885MAPT 2200/4885KDM4E 4194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback